Cost-effective market access strategy for medical technologies in Europe
A holistic approach to reimbursement strategies trusted by global market leaders and SMEs
Recent news and posts
New tests in the Spanish Catalog of Genetic and Genomic Tests from January 2025
In January 2025, the Common Catalog of Genetic and Genomic Tests of the National Health System was updated in Spain. A new section, “Respiratory medicine,” was added, including 29 tests for multiple respiratory diseases; some examples of diseases are provided below:
- Primary ciliary dyskinesia;
- Pulmonary interstitial disease related to surfactant proteins;
- Pulmonary alveolar proteinosis;
- Lymphangioleiomyomatosis (LAM);
- Cystic fibrosis;
- Methylmalonic acidemia with homocystinuria type cbIC;
- Idiopathic pulmonary arterial hypertension.
The Catalog is currently comprised of 701 tests.
See the full details in Spanish here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.